CTRI/2025/02/080464尚未招募2/3 期
AN OPEN-LABEL RANDOMISED CONTROL CLINICAL TRIAL TO ASSESS THE EFFICACY OF PANCHASAMA CHURNA ALONG WITH MAHARASNADI KWATHA AND SIMHANADA GUGGULU IN THE MANAGEMENT OF PAIN IN AMAVATA (RHEUMATOID ARTHRITIS) AFTER VIRECHANA AND IN SILICO EVALUATION OF PANCHASAMA CHURNA
Dr Anju S Raj1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2025年3月12日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 132
- 试验地点
- 1
- 主要终点
- • Reduction in Universal pain assessment
研究概览
简要总结
the study is a randomised control clinical trial to assesse the efficacy of Panchasama churna along with Maharasnadi kwatha and Simhanadagugguluin the management of pain in Amavata (Rheumatoid arthritis) after *Virechana .*Primary endpoint will beReduction in Universal pain assessment. Secondary endpoint will be Reduction of RA factor, CRP, ESR ,Improvement in DAS 28 scor , To provide relief in the cardinal symptoms of Amavata (RA) , Improvement in the quality of life of Amavata patients by using SF 36. Total partcipant for the trial will be 136 .
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 21.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients aged 21 to 60 years wishing to participate in the trial with a diagnosis of rheumatoid arthritis.
- •Includes both seropositive and seronegative cases.
- •Patients having the clinical manifestation of Amavata (RA) according to Ayurvedic classics -Sandhishool (pain), Shotha (swelling), Sparshasahata (tenderness) and Stabdhata (stiffness),Vrishichikadansavata vedana(pain like scorpion sting), Agnimandya (poor digestion) , Aruchi(anorexia), Gaurav(Feeling of heaviness of body),Utsaha Hani(lack of interest),Mukha vairasya(Perverted taste).
排除标准
- •patients unwilling to participate pregnant and lactating women Patients with major complications such as extra-articular manifestations are also excluded.
- •Patients with other systemic complications of RA like RHD, Rheumatic fever, pleural pericardial disease.
- •Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis, and psoriatic arthritis.
- •patients with poorly controlled diabetes and hypertension patients who is taking medicines for modern ailments.
结局指标
主要结局
• Reduction in Universal pain assessment
时间窗: baseline,after virechana ,4 weeks after virechana
次要结局
- Reduction of RA factor, CRP, ESR(Improvement in DAS 28 score)
研究者
Dr Anju S Raj
All India Institute of Ayurveda
研究点 (1)
Loading locations...
相似试验
尚未招募
3 期
To compare how well Panchsam Churna and Vaishvanar Churna work when used with Maharasnadi Kwath in AmvataCTRI/2025/07/091463Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan60
尚未招募
Phase 3 4
A STUDY TO SEE EFFECT OF LAKSHA CHURNA (Laccifera lacca)ALONG WITH MADHU PRATISARAN IN THE MANAGEMENT OF DANTSHARKARA W.S.R TARTAR AFTER DANTASHARKARA NIHARANA (ULTRASONICSCALING)CTRI/2025/07/090967Sst Ayurved mahavidyalay sangamner90
尚未招募
2/3 期
A Clinical trial to study the effect of Samangadi Churna in Academic stress in Adolescent age groupCTRI/2024/11/076649Institute For Ayurved Studies And Research30
尚未招募
2/3 期
Compare two interventional group to study the efficacy of Pippali churna and Vidarikand Churna in the management of stanyakshayCTRI/2025/04/085341Dr Sheela Natharo Bhalerao80
尚未招募
2/3 期
Clinical study to Evaluate The Efficacy Of Pippalyadi Churna With Ghrita In Oligomenorrhoea.CTRI/2026/02/104478Manjusha Rupchand Meshram120